Two Top Stories of Wall Street: Seattle Genetics, Inc. (NASDAQ:SGEN), Colfax Corporation (NYSE:CFX)

Seattle Genetics, Inc. (NASDAQ:SGEN)

The shares of Seattle Genetics, Inc. (NASDAQ:SGEN) started off the last trading session with the price of $57.47 while closing the day with the price of $58.68. The shares of Seattle Genetics, Inc. (NASDAQ:SGEN) Rise 2.61% with the Gain of 1.21 points.

The shares of Seattle Genetics, Inc. (NASDAQ:SGEN) traded with the day volume of 1.34 Million shares whereas its average trading volume is 1.21 Million.

While analyzing the past performance of the stock we can see that the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) Gain 7.26% in the last week while rising 16.11% in the last month. Past quarter performance shows the green light with 2.46%. The semi-annual and annual performance shows 10.74% and -13.66% respectively.

Some critical values of the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) to be discussed here are: the beta which shows the value at 1.85 while Average True Range of Seattle Genetics, Inc. (NASDAQ:SGEN) demonstrate the value at 2.21. The weekly and monthly volatility of the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) are indicated at 3.49% and 3.77%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 64.89.

While studying the financial position of the shares of Seattle Genetics, Inc. (NASDAQ:SGEN), we can see that the Market capitalization of the company is at 9.23 Billion. The shares outstanding for the company is 157.34 Million and the shares float stands at 156.18 Million. The income of the company stand at -10700000 while the sales stand at 482.3 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.09, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 19.14, the Return on Asset ROA stood at -0.153 and the Return on Equity ROE depicted at -0.2 while Return on Investment ROI is at -0.07.


Colfax Corporation (NYSE:CFX)

Colfax Corporation (NYSE:CFX) started its previous trading session at $33.77 and closed at $33.5 showing a Fell of -0.83 Percent.

The Company traded with an average Volume of 899.54 Million whereas, its Day Volume stood at 455638.

Looking at the performance of the stock, Colfax Corporation (NYSE:CFX) Gain 3.84% in the last week in its shares price and 1.67% in the last month. Quarterly performance shows a red of -8.34 Percent while Semi-Annual and Annual performances shows a -15.57 and -13.68 percent respectively.

Beta for Colfax Corporation (NYSE:CFX) stands at 1.29 while the ATR (average true range) is at 1.02. The Stock’s Weekly and Monthly Volatility is 2.20% and 2.74% respectively showing a RSI value of 43.16.

While studying the financial position of the shares of Colfax Corporation (NYSE:CFX), we can see that the Market capitalization of the company is at 4.07 Billion. The shares outstanding for the company is 121.44 Million and the shares float stands at 99.32 Million.

The Company generated an income of -75600000 and the sales of 3.3 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.62 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1.23 respectively.

The Return on Assets stands at 0.023, ROE shows a value of 0.047 and ROI for Colfax Corporation (NYSE:CFX) is -0.004 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment